| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 33.329 | 32.659 | 47.660 | 46.602 | 50.687 | 46.582 | 25.021 | 22.318 | 34.629 | 0 |
| Total Income - EUR | 33.386 | 34.220 | 48.184 | 46.602 | 55.366 | 48.887 | 25.330 | 23.383 | 34.629 | 0 |
| Total Expenses - EUR | 32.062 | 32.055 | 32.498 | 36.564 | 48.281 | 31.980 | 47.635 | 43.987 | 14.962 | 15.263 |
| Gross Profit/Loss - EUR | 1.324 | 2.165 | 15.686 | 10.038 | 7.085 | 16.907 | -22.306 | -20.604 | 19.667 | -15.263 |
| Net Profit/Loss - EUR | 322 | 1.815 | 15.200 | 9.575 | 6.532 | 16.420 | -22.561 | -20.838 | 16.138 | -15.263 |
| Employees | 4 | 3 | 2 | 2 | 2 | 1 | 2 | 1 | 0 | 0 |
Check the financial reports for the company - Teknocasa Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 461 | 1.826 | 3.599 | 2.557 | 1.646 | 7.359 | 6.235 | 2.570 | 1.445 | 2.023 |
| Current Assets | 9.293 | 3.763 | 10.913 | 7.537 | 10.199 | 26.975 | 16.120 | 20.471 | 24.324 | 20.154 |
| Inventories | 1.466 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 7 | 7 |
| Receivables | 7.794 | 3.641 | 3.803 | 3.142 | 275 | 14.777 | 15.018 | 19.052 | 22.019 | 19.185 |
| Cash | 33 | 122 | 7.110 | 4.395 | 9.924 | 12.198 | 1.102 | 1.412 | 2.298 | 962 |
| Shareholders Funds | -24.926 | -22.856 | -7.268 | 2.439 | 8.924 | 25.174 | 2.055 | -18.777 | -2.582 | -17.831 |
| Social Capital | 2.250 | 2.227 | 2.189 | 2.149 | 2.107 | 2.067 | 2.022 | 2.028 | 2.022 | 2.010 |
| Debts | 34.680 | 28.445 | 21.781 | 7.654 | 1.610 | 8.367 | 19.513 | 41.147 | 27.955 | 39.227 |
| Income in Advance | 0 | 0 | 0 | 0 | 1.362 | 804 | 786 | 788 | 786 | 782 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6831 - 6831" | |||||||||
| CAEN Financial Year |
6831
|
|||||||||
Comments - Teknocasa Intermed Srl